17X

(2S)-2-(2-phenyl-1H-benzimidazol-1-yl)-2-(piperidin-4-yl)ethyl 1-(1-benzyl-1H-benzimidazol-2-yl)piperidine-4-carboxylate

Created:	2013-03-26
Last modified:	2013-05-22

Find Related PDB Entry
1 entries where 17X is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	90
Chiral Atom Count	1
Bond Count	97
Aromatic Bond Count	32

2D diagram of 17X

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-2-(2-phenyl-1H-benzimidazol-1-yl)-2-(piperidin-4-yl)ethyl 1-(1-benzyl-1H-benzimidazol-2-yl)piperidine-4-carboxylate
Systematic Name (OpenEye OEToolkits)	[(2S)-2-(2-phenylbenzimidazol-1-yl)-2-piperidin-4-yl-ethyl] 1-[1-(phenylmethyl)benzimidazol-2-yl]piperidine-4-carboxylate
Formula	C₄₀ H₄₂ N₆ O₂
Molecular Weight	638.8
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(OCC(n2c3ccccc3nc2c1ccccc1)C4CCNCC4)C8CCN(c5nc7c(n5Cc6ccccc6)cccc7)CC8
SMILES	CACTVS	3.370	O=C(OC[CH](C1CCNCC1)n2c3ccccc3nc2c4ccccc4)C5CCN(CC5)c6nc7ccccc7n6Cc8ccccc8
SMILES	OpenEye OEToolkits	1.7.6	c1ccc(cc1)Cn2c3ccccc3nc2N4CCC(CC4)C(=O)OCC(C5CCNCC5)n6c7ccccc7nc6c8ccccc8
Canonical SMILES	CACTVS	3.370	O=C(OC[C@H](C1CCNCC1)n2c3ccccc3nc2c4ccccc4)C5CCN(CC5)c6nc7ccccc7n6Cc8ccccc8
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1ccc(cc1)Cn2c3ccccc3nc2N4CCC(CC4)C(=O)OC[C@H](C5CCNCC5)n6c7ccccc7nc6c8ccccc8
InChI	InChI	1.03	InChI=1S/C40H42N6O2/c47-39(32-21-25-44(26-22-32)40-43-33-15-7-9-17-35(33)45(40)27-29-11-3-1-4-12-29)48-28-37(30-19-23-41-24-20-30)46-36-18-10-8-16-34(36)42-38(46)31-13-5-2-6-14-31/h1-18,30,32,37,41H,19-28H2/t37-/m1/s1
InChIKey	InChI	1.03	WDALFJYWTFDSRP-DIPNUNPCSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3286930
PubChem	90644544
ChEMBL	CHEMBL3286930

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.